|
CZ423797A3
|
|
Topic eye preparations containing immunosuppressive substances
|
|
CZ312097A3
|
|
Process for preparing 9,10-dihydroergopeptins
|
|
CZ228996A3
|
|
Cyclosporin containing medicinal preparations
|
|
CZ16996A3
|
|
Therapeutic preparations containing cyclosporin
|
|
CZ282794A3
|
|
Pentapeptidic precursors of biologically active cyclic dipeptides
|
|
CZ245694A3
|
|
Novel industrial production strain of Claviceps paspali microorganism
|
|
CZ280553B6
|
|
Strain mycelium sterilae ms 2929, producing cyclosporins in conditions of submesible fermentation
|
|
CZ111994A3
|
|
Strain tolypocladium sp.ms 3029, deposited under ccm 8185 for producing cyclosporins in conditions of stationary fermentation
|
|
CZ166993A3
|
|
Process for preparing 3,14beta-dihydroxy-17-normorphinan
|
|
CZ281130B6
|
|
Derivatives of 4-alkoxy-3-propyl-2-hydroxyacetophenone
|
|
CZ279821B6
|
|
Process for preparing (6r, 7r, 14s)-17-cyclopropylmethyl 7,8-dihydro-7-/(1s)-1-hydroxy-1,2,2-trimethylpropyl/ -6-0-methyl-6,14-ethano-17-normorphine
|
|
CZ16393A3
|
|
Process for preparing 3,14 beta-dihydroxy-17-cycloalkyl methylmorphinans
|
|
CZ8493A3
|
|
Isolation process of crystalline silybin and silymarin
|
|
CZ354692A3
|
|
Medicament
|
|
CZ277092A3
|
|
Medicinal preparations with n-methylated cyclic undecapeptides
|
|
CZ239691A3
|
|
Novel industrial strain of micro-organisms claviceps purpurea (fr.) tul., ccm 8058
|
|
CS25191A3
|
|
Directed polymeric conjugates of cyclosporin
|
|
CS483190A3
|
|
Process for preparing n-(d-6-methyl-8{alpha}-ergolenyl)-n',n'-diethylurea
|
|
CS9001114A2
|
|
Process for preparing n-(d-6-methyl-8-isoergolinyl)-n',n'-diethyl urea
|
|
CS276333B6
|
|
Process for preparing activated killing cells
|
